<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22950" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biochemistry, HLA Antigens</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nordquist</surname>
            <given-names>Helen</given-names>
          </name>
          <aff>University of New Mexico</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jamil</surname>
            <given-names>Radia T.</given-names>
          </name>
          <aff>Allama Iqbal Medical College</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Helen Nordquist declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Radia Jamil declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22950.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Human leukocyte antigens (HLA) are genes in major histocompatibility complexes (MHC) that help code for proteins that differentiate between self and non-self. They play a&#x000a0;significant role in disease and immune defense. They are beneficial to the immune system but can also have detrimental effects. Some of the immune system effects are the interaction with complement, the cytotoxic effect of T cells, and cellular humoral immunity. Additionally, they play a role in autoimmunity and continue to be the target of researchers for their further effects and interactions.<xref ref-type="bibr" rid="article-22950.r1">[1]</xref></p>
      </sec>
      <sec id="article-22950.s2" sec-type="Fundamentals">
        <title>Fundamentals</title>
        <p>Human leukocyte antigens are of three main types. Class I HLA antigens include HLA-A, B, and C molecules; class II, which includes HLA-DR, -DQ, and -DP loci, are on antigen-presenting cells; and class III contains genes for proteins that have immune functionality.<xref ref-type="bibr" rid="article-22950.r1">[1]</xref></p>
      </sec>
      <sec id="article-22950.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>HLA antigen sensitization can become a problem for patients undergoing procedures such as stem cell transplants. HLA antigens have a significant role in transplant-mediated rejection, which falls under the following two categories:</p>
        <p>
<bold>T-cell-mediated Rejection</bold>
</p>
        <p>In T-cell-mediated rejection, the T-cell becomes activated because of the interaction between the T-cell receptor and the HLA-peptide combination from the donor.</p>
        <p>
<bold>Antibody-mediated Rejection</bold>
</p>
        <p>In antibody-mediated rejection, the T-helper cells are co-stimulated, and there is a concurrent inflammatory response, leading to the recognition of foreign HLA molecules.&#x000a0;</p>
        <p>Due to the possibility of these two types of rejection, laboratories measure the HLA antibodies in circulation to determine the risk of rejection.<xref ref-type="bibr" rid="article-22950.r1">[1]</xref></p>
        <p>HLA types also had correlations with an increased risk of particular diseases. For example, early-onset myasthenia gravis correlates with HLA-B8 as the unique genetic factor that leads to the onset of the disease.<xref ref-type="bibr" rid="article-22950.r2">[2]</xref> Although of unknown etiology, multiple sclerosis has been shown to have a high rate of correlation with the HLA-DR2 antigen.<xref ref-type="bibr" rid="article-22950.r3">[3]</xref> Additionally, rheumatoid arthritis (RA) has been shown to precipitate complex biological interactions in the body. Some of these interactions include HLA-DR4, a glycopeptide from type II collagen, and a T-cell receptor, shown to be correlated with the development of RA.<xref ref-type="bibr" rid="article-22950.r4">[4]</xref></p>
      </sec>
      <sec id="article-22950.s4" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>The HLA class I is present on all nucleated cell surfaces and presents intracellular peptides to cytotoxic T-cells in the immune system.<xref ref-type="bibr" rid="article-22950.r4">[4]</xref></p>
        <p>HLA plays a role in cellular immunity, particularly noted in transplant reactions. Particular antibodies, such as anti-HLA-B and anti-HLA-DQ, can bind complement.<xref ref-type="bibr" rid="article-22950.r5">[5]</xref></p>
      </sec>
      <sec id="article-22950.s5" sec-type="Molecular Level&#x0000d;&#x0000a;">
        <title>Molecular Level
</title>
        <p>HLA antigens can be variable, and researchers have investigated their presence and function to determine their use in disease diagnosis and treatment. HLA polymorphisms can change depending on the epidemiological composition of a particular population, so this presents an important&#x000a0;area of research to further delve into as technology progresses. Studies can be performed on specific demographics of humans to find out more about the presence of particular diseases that have a predilection in certain groups. For example, in 2018, a trial was conducted in Thailand to evaluate the efficacy of a Dengue vaccine. The HLA antigens were mapped in the population, and researchers identified 201 different HLA antigens through next-generation sequencing techniques. Through this investigation, researchers identified HLA alleles with higher frequencies in the population and could incorporate that information and begin applying it to disease association in the population.<xref ref-type="bibr" rid="article-22950.r6">[6]</xref></p>
      </sec>
      <sec id="article-22950.s6" sec-type="Function">
        <title>Function</title>
        <p>HLA antigens, particularly the A, B, and C loci, are highly variable, especially in the extracellular domains, as evidenced by the over 300 class I alleles that researchers have identified.<xref ref-type="bibr" rid="article-22950.r5">[5]</xref> The parts of the HLA antigens that are the most variable reside near the peptide-binding groove. The variability&#x000a0;alters the interactions with T-cell receptors and the peptide-binding specificity; this changes the function of the HLA antigens, which can alter the immune response and disease resistance.<xref ref-type="bibr" rid="article-22950.r4">[4]</xref></p>
        <p>In addition to their variability and function as peptide receptors, they act at different sites with beta-2-microglobulin, an alpha-beta T-cell receptor, and inhibitory molecules.<xref ref-type="bibr" rid="article-22950.r7">[7]</xref> The various alleles within each class of HLA antigens allow for these additional functions.</p>
      </sec>
      <sec id="article-22950.s7" sec-type="Testing">
        <title>Testing</title>
        <p>Types of tests include cellular assays, immunologic, and molecular tests.</p>
        <p>Conventionally, HLA classes are detected by the polymerase chain reaction (PCR). PCR uses variable exon sequences that encode the first amino-terminal from the HLA domains. From there, the HLA sequences from the database are used in hybridization with the amplified PCR products.<xref ref-type="bibr" rid="article-22950.r8">[8]</xref></p>
        <p>There have also been recent developments in less expensive assays to detect specific HLA antigens, such as high-resolution melting assays.<xref ref-type="bibr" rid="article-22950.r9">[9]</xref></p>
        <p>The standard technique for identifying HLA class I and class II antigens has been the complement-mediated microlymphocytotoxicity technique. In this technique, HLA sera are obtained from alloimmunized women, and those specificities get determined by matching against a panel with already known HLA types.<xref ref-type="bibr" rid="article-22950.r8">[8]</xref></p>
        <p>Testing for HLA antigens often is by bead-based multiplexed immunoassay system technology. In this test, HLA protein beads coat the surface of microspheres. A fluorescence quantification system measures the level of HLA antibody binding to each of the beads.&#x000a0;</p>
        <p>Testing in patients with HLA antibodies in their circulation requires a cross-match before transplantation. This traditional cross-match entails patient serum mixed with lymphocytes that have derived from the donor. "Virtual" cross matches may also be done to estimate the transplant risk by measuring the levels of circulating HLA antibody using single antigen beads and bead-based multiplexed immunoassay system technology.<xref ref-type="bibr" rid="article-22950.r3">[3]</xref></p>
      </sec>
      <sec id="article-22950.s8" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Often, the specific pathophysiology for how HLA antigens are associated with a disease is not well known. However, HLA antigens play a role in autoimmunity. For example, in type I diabetes mellitus, the DR3-DQ2 haplotype is seen at an increased percent compared to the general population. The same haplotype is also associated with juvenile autoimmune thyroiditis. Other haplotypes can be protective for diseases, such as DRB1*14:01, which has protective effects against type I diabetes.<xref ref-type="bibr" rid="article-22950.r10">[10]</xref></p>
      </sec>
      <sec id="article-22950.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Graft-versus-host Disease</bold>
</p>
        <p>A major clinical significance of HLA antigens is their role in transplant rejection.</p>
        <p>The opposite&#x000a0;can occur when immune cells get transplanted with the graft into the recipient. Hematopoietic progenitor cell transplantation (e.g., bone marrow, stem cells) must mainly deal with this phenomenon. Graft-versus-host disease (GVHD) is&#x000a0;caused by the presence of donor antibodies against HLA class II antigens. One study at Henri-Mondor University Hospital in France demonstrated that when donors have antibodies against the specific recipient HLA antigens, there is a correlation with the incidence of GVHD.<xref ref-type="bibr" rid="article-22950.r3">[3]</xref></p>
        <p>A study in the UK of stem cell transplants between 1996 and 2003 showed that patients with a class I HLA mismatch were more likely to developed chronic GVHD. Additionally, the pairs that had the mismatches also had a higher mortality rate after one year. Multiple HLA mismatches show higher rates of GVHD.<xref ref-type="bibr" rid="article-22950.r11">[11]</xref></p>
        <p>HLA antigens&#x000a0;can be matched when administering blood products. Research has demonstrated that blood banks that use the HLA genotypes of the blood donors have better transfusion outcomes. There has been a discussion of the possibility of creating a database with genotyped donors to make it slightly easier to find blood for patients with rare HLA antibodies so that their transfusions can have less risk of adverse outcomes because of having matched donors.<xref ref-type="bibr" rid="article-22950.r12">[12]</xref></p>
        <p>As discussed above, studies have identified particular HLA antigens have as correlating with disease processes. These allow for the development of specific treatments for diseases.</p>
        <p>
<bold>Multiple Sclerosis</bold>
</p>
        <p>HLA-DR2 is associated with multiple sclerosis. Since there is such a strong association between the disease and the antigen, there have been studies looking at immunotherapy to target the DR2 antigen in the treatment of the disease. In one particular study, the molecule PV-267 was examined for its promise as a therapy. PV-267 functions as a cytokine inhibitor and inhibits the proliferation of myelin-specific DR2 antigens. By using PV-267 derived from multiple sclerosis patients, researchers found the potential for further therapeutic options.<xref ref-type="bibr" rid="article-22950.r13">[13]</xref></p>
        <p>
<bold>Rheumatoid Arthritis </bold>
</p>
        <p>Rheumatoid arthritis shows strong associations with DR4. These have been thought to indicate disease susceptibility. When DR4 binds with a class II-associated peptide, it may indicate an increased risk for rheumatoid arthritis. The DR4 binding changes the presentation of the citrullinated peptides, contributing to the development of the disease.<xref ref-type="bibr" rid="article-22950.r14">[14]</xref></p>
        <p>
<bold>Graves Disease</bold>
</p>
        <p>Graves disease is associated with HLA-DR3. In addition to environmental factors, the HLA haplotype plays a significant role in disease development. Important clinically, HLA typing may help to predict the outcome of Graves disease before and post-antithyroid medical therapy.<xref ref-type="bibr" rid="article-22950.r15">[15]</xref> The typing can be used to associate increased and decreased allele values during therapy.<xref ref-type="bibr" rid="article-22950.r16">[16]</xref></p>
        <p>
<bold>Beh&#x000e7;et Disease</bold>
</p>
        <p>Beh&#x000e7;et disease is associated with HLA-B51, which influences the clinical features of the disease. Patients with the HLA-B51 haplotype have been shown to develop symptoms of the disease earlier in life (less than 40 years of age). Additionally, neurological and gastrointestinal symptoms of the disease were more prevalent in patients without the HLA-B51 haplotype rather than those who had it.<xref ref-type="bibr" rid="article-22950.r17">[17]</xref></p>
      </sec>
      <sec id="article-22950.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22950&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22950">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22950/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22950">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22950.s11">
        <fig id="article-22950.image.f1" position="float" orientation="portrait">
          <caption>
            <p>HLA/MHC gene polymorphism, structure, and mechanism Contributed from the Wikimedia Gallery (CC BY-2.5 https://creativecommons.org/licenses/by/2.5/)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MHC__images" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22950.s12">
        <title>References</title>
        <ref id="article-22950.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carey</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Poulton</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Poles</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Factors affecting HLA expression: A review.</article-title>
            <source>Int J Immunogenet</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>307</fpage>
            <page-range>307-320</page-range>
            <pub-id pub-id-type="pmid">31183978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gotfredsen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>P&#x000f8;denphant</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>N&#x000f8;rgaard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nilas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Christiansen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of lumbar spine bone mineral content by dual photon absorptiometry.</article-title>
            <source>J Nucl Med</source>
            <year>1988</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>248</fpage>
            <page-range>248-54</page-range>
            <pub-id pub-id-type="pmid">3346735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delbos</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Barhoumi</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Cabanne</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Beckerich</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Robin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Redjoul</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Astati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Toma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pautas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ansart-Pirenne</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cordonnier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bierling</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maury</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease.</article-title>
            <source>Biol Blood Marrow Transplant</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>292</fpage>
            <page-range>292-299</page-range>
            <pub-id pub-id-type="pmid">26453972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parham</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Function and polymorphism of human leukocyte antigen-A,B,C molecules.</article-title>
            <source>Am J Med</source>
            <year>1988</year>
            <month>Dec</month>
            <day>23</day>
            <volume>85</volume>
            <issue>6A</issue>
            <fpage>2</fpage>
            <page-range>2-5</page-range>
            <pub-id pub-id-type="pmid">2462346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ayna</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Ko&#x000e7;y&#x00130;&#x0011f;&#x00130;t</surname>
                <given-names>A&#x000d6;</given-names>
              </name>
              <name>
                <surname>Soypa&#x000e7;aci</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Tu&#x0011f;men</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pirim</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Investigation of Anti-HLA Antibodies of Highly Sensitized Patients by Single Antigen Bead and C1q Tests.</article-title>
            <source>Transplant Proc</source>
            <year>2019</year>
            <month>May</month>
            <volume>51</volume>
            <issue>4</issue>
            <fpage>1024</fpage>
            <page-range>1024-1026</page-range>
            <pub-id pub-id-type="pmid">31101164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geretz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ehrenberg</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Bouckenooghe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez Vi&#x000f1;a</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Michael</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Chansinghakule</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Limkittikul</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Full-length next-generation sequencing of HLA class I and II genes in a cohort from Thailand.</article-title>
            <source>Hum Immunol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>79</volume>
            <issue>11</issue>
            <fpage>773</fpage>
            <page-range>773-780</page-range>
            <pub-id pub-id-type="pmid">30243890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kostyu</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Hannick</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>Traweek</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ghanayem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heilpern</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>DV</given-names>
              </name>
            </person-group>
            <article-title>HLA class I polymorphism: structure and function and still questions.</article-title>
            <source>Hum Immunol</source>
            <year>1997</year>
            <month>Sep</month>
            <day>15</day>
            <volume>57</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-18</page-range>
            <pub-id pub-id-type="pmid">9438190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smirnova</surname>
                <given-names>LI</given-names>
              </name>
            </person-group>
            <article-title>[Climacteric cardioneurosis].</article-title>
            <source>Feldsher Akush</source>
            <year>1989</year>
            <month>Dec</month>
            <volume>54</volume>
            <issue>12</issue>
            <fpage>54</fpage>
            <page-range>54-7</page-range>
            <pub-id pub-id-type="pmid">2628004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imperiali</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Al&#x000ed;a-Ramos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Padr&#x000f3;-Miquel</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Rapid detection of HLA-B*51 by real-time polymerase chain reaction and high-resolution melting analysis.</article-title>
            <source>Tissue Antigens</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>86</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-42</page-range>
            <pub-id pub-id-type="pmid">26176813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fawwad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Govender</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ahmedani</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Basit</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Atkinson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Henry Wasserfall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ogle</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Noble</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Clinical features, biochemistry and HLA-DRB1 status in youth-onset type 1 diabetes in Pakistan.</article-title>
            <source>Diabetes Res Clin Pract</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>149</volume>
            <fpage>9</fpage>
            <page-range>9-17</page-range>
            <pub-id pub-id-type="pmid">30710658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shaw</surname>
                <given-names>BE</given-names>
              </name>
            </person-group>
            <article-title>The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation.</article-title>
            <source>Int J Immunogenet</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>4-5</issue>
            <fpage>367</fpage>
            <page-range>367-74</page-range>
            <pub-id pub-id-type="pmid">18976440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dutra</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Bub</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Bastos</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Aravechia</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Kutner</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Allele and haplotype frequencies of human platelet and leukocyte antigens in platelet donors.</article-title>
            <source>Einstein (Sao Paulo)</source>
            <year>2019</year>
            <month>Feb</month>
            <day>07</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>eAO4477</fpage>
            <pub-id pub-id-type="pmid">30758400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andrews</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Damjanov</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Mixed glycosidase pretreatment reduces nonspecific binding of antibodies to frozen tissue sections.</article-title>
            <source>J Histochem Cytochem</source>
            <year>1985</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>7</issue>
            <fpage>695</fpage>
            <page-range>695-8</page-range>
            <pub-id pub-id-type="pmid">3891844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miyadera</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tokunaga</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.</article-title>
            <source>J Hum Genet</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>60</volume>
            <issue>11</issue>
            <fpage>697</fpage>
            <page-range>697-702</page-range>
            <pub-id pub-id-type="pmid">26290149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsuo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ushiroda</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>IDENTICAL TWIN SISTERS WITH CLOSE ONSET OF GRAVES' DISEASE AND WITH MULTIPLE HLA SUSCEPTIBILITY ALLELES FOR GRAVES' DISEASE.</article-title>
            <source>Acta Endocrinol (Buchar)</source>
            <year>2016</year>
            <season>Jan-Mar</season>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>91</fpage>
            <page-range>91-95</page-range>
            <pub-id pub-id-type="pmid">31258808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vita</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lapa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Trimarchi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vita</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fallahi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Benvenga</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.</article-title>
            <source>Endocrine</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>55</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-100</page-range>
            <pub-id pub-id-type="pmid">26951052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22950.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryu</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51.</article-title>
            <source>Korean J Intern Med</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>1025</fpage>
            <page-range>1025-1031</page-range>
            <pub-id pub-id-type="pmid">28073242</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
